Professional Summary
Professional Overview
Beth Taylor is an accomplished Chief Financial Officer with a strong track record of driving financial strategy and operational excellence across diverse industries. With over 30 years of experience, she leverages her exceptional financial acumen, strategic leadership, and deep industry knowledge to guide organizations through complex business transformations and achieve sustainable growth.
Experience Summary
Current Role
As the Chief Financial Officer at Inotiv, Beth is responsible for overseeing all financial operations, including financial planning and analysis, treasury management, tax compliance, and risk management. She plays a pivotal role in aligning the company's financial strategy with its broader business objectives, ensuring the effective allocation of resources and the optimization of financial performance.
Career Progression
Prior to joining Inotiv, Beth held several senior finance roles, including Vice President of Finance and Chief Accounting Officer at Endocyte, Inc., and Corporate Controller at Endocyte, Inc., Author Solutions, Inc., and Harlan Laboratories, Inc. She also served as VP/Controller at Republic Airways Holdings and Manager of Accounting at Rolls-Royce. Beth started her career as a Senior Auditor at Deloitte & Touche, where she honed her expertise in financial reporting, internal controls, and compliance.
Throughout her career, Beth has demonstrated a strong ability to drive strategic financial initiatives, improve operational efficiency, and enhance financial reporting and internal controls. Her experience spans a range of industries, including life sciences, aviation, and manufacturing, allowing her to bring a diverse perspective and a deep understanding of financial best practices to her current role.
Academic Background
Beth holds a Bachelor of Science degree in Accounting from Indiana University.
Areas of Expertise
- Financial planning and analysis
- Treasury management
- Tax compliance and optimization
- Risk management and internal controls
- Financial reporting and accounting
- Strategic financial decision-making
- Cross-functional collaboration and leadership
- Business transformation and operational optimization
Professional Impact
During her tenure at Endocyte, Inc., Beth played a pivotal role in the company's successful $2.1 billion acquisition by Novartis, leading the financial integration and ensuring a seamless transition. At Inotiv, she has been instrumental in driving the company's financial strategy, which has contributed to its strong growth and profitability.
Conclusion
With her extensive experience, strong financial acumen, and strategic leadership, Beth Taylor is poised to continue making a significant impact as the Chief Financial Officer at Inotiv. Her ability to navigate complex financial challenges, drive operational efficiency, and align financial strategy with business objectives make her a valuable asset to the organization.
